CE1351

The Art and Science of Anxiolysis and Sedation in 2014 and Beyond – Nitrous Oxide and Oral Sedation

Fred Quarnstrom, DDS, FADSA, FAGD, FICD, FACD, CDC;
David Donaldson, BDS, FDSRCS, MDS, FADSA, FACD, FAAOP, FICD;
Mark Donaldson, BSP, PHARM D, FASHP, FACHE

This course can satisfy the requirement in Washington State (WAC 246-817-701 through -790), Oregon State (§818-026), Idaho State (§19.01.01.060.01), Alberta (Modality 3 Standards for the Use of Sedation in Non‐Hospital Dental Practice) and the American Dental Association. Actual number of hours required by each state can vary.

DATE:
Friday, February 7, Saturday, February 8 and/or Sunday, February 9, 2014

LOCATION:
Friday:
University of Washington
Center for Urban Horticulture
NHS Hall
3501 NE 41st Street
Seattle, Washington 98105

Saturday:
University of Washington
Health Sciences Center
Turner Auditorium, Room D-209
Seattle, Washington 98195

Sunday:
University of Washington
Health Sciences Center
Turner Auditorium, Room D-209
Seattle, Washington 98195

TARGET AUDIENCE:
This course is applicable for all dental professionals interested in providing minimal and moderate sedation in their office, and is an excellent refresher for those practitioners already experienced with these modalities.

REGISTER:
Download Course Application Form
or
Register Online (available until two days before the course).

TIMES:
Registration and Continental Breakfast: 8:00am – 8:30am
Course: 8:30am – 4:30pm

TUITION – price includes lunch:
Before February 5 (after, $10 more)
$399/Dentist – per day
$249/Dental Hygienist, Dental Assistant and Office Staff – per day
$359/Current Dental Alumni Member – per day

CREDITS: 7, 14 or 21 hours

* This course is eligible for a 10% tuition discount if you are a current member of the UW Dental Alumni Association.

TOPICS FOR EACH DAY:
See below.

* Wondering how many hours of continuing ed you need?

Course Description

Dental practitioners, hygienists and team members interested in providing safe and effective minimal and moderate sedation for their patients should come to this course. For those practitioners already familiar with these modalities, this course represents the most comprehensive and up‐to‐date approaches for ensuring successful outcomes for you, your Team, and your patients. The curriculum is designed to meet the ADA guidelines and will review state‐wide adaptations based on these recommendations. Our experienced faculty offer a multimedia approach, including relevant and useful pharmacology, and have taught over 20,000 dentists how to safely sedate dental patients. Whether you are interested in getting started, or have been using these tools for years, we will provide practical information taught by top professionals in this field.

Instruction in all aspects of inhalational analgesia and oral conscious sedation, including effective methods in dealing with anxiety control in general practice will be discussed. Participants will learn various techniques and protocols designed to achieve certification in nitrous oxide/oxygen sedation as well as competency in providing oral anxiolysis. A patient‐centered approach to care is emphasized with lectures on appropriate patient selection, medication selection, necessary monitoring and practical emergency management. Case studies will augment the delivery of key points and a problem‐based learning approach is encouraged to that each participant’s questions are addressed.

Course Objectives

As a result of attending this course, you should be able to:

  • Describe the most recent ADA guidelines and State Regulations for anxiolysis and sedation.
  • Provide safe and effective anxiolysis and sedation using oral and inhalational techniques.
  • Identify and describe areas of controversy regarding traditional dental relaxation methods and approaches to analgesia.
  • Discuss new pharmacologic agents and their optimal use in dentistry.
  • Understand why some drugs work and some don’t for postoperative dental pain.
  • Understand the principles of drug metabolism including liver enzyme induction and inhibition.
  • Modify dental treatment in relation to overall therapeutic regimen and recognize and manage potential emergencies.
  • Discuss local anesthetic controversies, equipment and techniques useful for the overall treatment of the anxious patient.

Course Schedule

Topics to be covered each day:

Friday’s Topics

  • Etiology of Dental Anxiety & Comparison of Techniques – Why Oral Sedation?
  • Pharmacology of Oral Sedatives
  • Reversal Agents and Flumazenil
  • Oral Sedation Techniques, Protocols and Case Studies
  • What’s in Your Emergency Kit and Practical Sessions on Airway
  • Local Anesthesia Update
  • Oral Sedation “Politics”, Rules and Regulations

Saturday’s Topics

  • From Inhalation to Intravenous Sedation
  • Pharmacology 101
  • Applied Physiology & Anatomy of Respiration
  • Nitrous Oxide Equipment
  • Pain Theory
  • Incremental Induction techniques
  • First Clinic
  • Drug Interactions and Databases

Sunday’s Topics

  • Medical Emergencies
  • Second Demonstration – Rapid Induction Technique
  • Second Clinic
  • Nitrous Oxide Installation
  • Nitrous Oxide and Oxygen Pharmacology
  • Medical Emergencies Continued
  • Contamination and Scavenging
  • Nitrous Oxide Complications / Contraindications

Instructors

FRED QUARNSTROMFRED QUARNSTROM is a Dental Anesthesiologist who received his DDS degree from the University of Washington School of Dentistry, and was a postgraduate resident in anesthesiology at Washington Hospital Center in Washington, D.C. He is a member of the American Dental Society of Anesthesiology, the International College of Dentistry, a Fellow in the Academy of General Dentistry, and a Diplomat of the American Dental Board of Anesthesiology.

Currently, Dr. Quarnstrom is an Affiliate Assistant Professor at the University of Washington School of Dentistry, and maintains a general practice in Seattle, Washington. He has lectured extensively on nitrous oxide/oxygen analgesia and was a pioneer in establishing the effectiveness of benzodiazepines for use in oral sedation.

DAVID DONALDSONDAVID DONALDSON obtained his dental degree at St. Andrews University in Scotland, and completed his Fellowship in Dental Surgery through the Royal College of Surgeons in Edinburgh. Upon earning his Masters degree in Restorative Dentistry at Dundee University, he assumed the position of Director of Pain and Anxiety Control in the Faculty of Dentistry at the University of British Columbia.

Since then he has held many positions, including Assistant Dean, Chairman of Curriculum, Member of the University Senate and Head of three departments. His teaching and research interests have mainly been in anesthesia and pain control, and in recognition of his achievements he was elected to the Fellowship in the American Dental Society of Anesthesia. In 1994, Dr. Donaldson was appointed as a Diplomat of the American Academy of Pain Management. His scientific publications and presentations are extensive,
and he has co‐authored several textbooks. He has presented over 1000 continuing education courses for dentists, dental hygienists, and physicians.

MARK DONALDSONMARK DONALDSON received his B.Sc.(Pharm.) from the University of British Columbia, and his Doctorate in Clinical Pharmacy from the University of Washington. He completed a residency at Vancouver General Hospital, and is the current Director of Pharmaceutical Services at the Kalispell Regional Medical Center in Kalispell, Montana.

Dr. Donaldson is a Clinical Professor in the Department of Pharmacy at the University of Montana in Missoula, and Clinical Associate Professor in the School of Dentistry at the Oregon Health & Sciences University in Portland, Oregon. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. He has been a primary author and investigator for the National Institutes of Health (NIH) Consensus Development Committee to define the guidelines for enteral sedation in the United States, as well as an invited expert to compose a whitepaper on Enteral Conscious Sedation for the Academy of General Dentistry (AGD). Dr. Donaldson is a reviewer for the American Journal of Health‐System Pharmacy and General Dentistry, and sits on the Editorial Board for the Journal of the American Dental Association (JADA).


ada cerp logo

The University of Washington is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

acde logo

The University of Washington is a member of the Association for Continuing Dental Education.

University of Washington designates this activity for 7, 14, or 21 continuing education credits.

Comments are closed.